These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2864241)

  • 1. Effect of simultaneous infusion of a somatostatin analogue, insulin and glucose on serum triglycerides and blood glucose levels in man.
    Fukushima H; Maeda H; Suzaki K; Shimada M; Sakakida M; Kishikawa H; Nakamura N; Uzawa H
    Endocrinol Jpn; 1985 Apr; 32(2):241-8. PubMed ID: 2864241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.
    Lien E; Sarantakis D
    Diabetologia; 1979 Jul; 17(1):59-64. PubMed ID: 467854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the new somatostatin analogue (BIM 23014) on blood glucose homeostasis in normal men.
    Kuhn JM; Basin C; Mollard M; De Rouge B; Schatz B; Wolf LM
    Eur J Clin Invest; 1992 Dec; 22(12):793-9. PubMed ID: 1478250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics.
    Neuhaus C; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):115-8. PubMed ID: 395066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.
    Møller N; Bagger JP; Schmitz O; Jørgensen JO; Ovesen P; Møller J; Alberti KG; Orskov H
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1789-93. PubMed ID: 7775624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The somatostatin infusion test for the evaluation of glucose utilization in bezafibrate medication].
    Vogelberg KH; Müller HJ; Hübinger A
    Arzneimittelforschung; 1984; 34(9):1038-41. PubMed ID: 6150716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus.
    Spinas GA; Bock A; Keller U
    Diabetes Care; 1985; 8(5):429-35. PubMed ID: 2865093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of somatostatin-induced suppression of postprandial insulin response upon the hypertriglyceridemia associated with a high carbohydrate diet.
    Ginsberg HN; Jacobs A; Le NA; Sandler J
    J Clin Invest; 1982 Dec; 70(6):1225-33. PubMed ID: 6129260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of somatostatin on blood sugar, plasma growth hormone, and glucagon levels in diabetic children.
    Del Guercio MJ; di Natale B; Gargantini L; Garlaschi C; Chiumello G
    Diabetes; 1976 Jul; 25(7):550-3. PubMed ID: 1278605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclic somatostatin on insulin, C-peptide and immunoreactive glucagon response to oral glucose loading in obese patients.
    Papalia D; Trovato G; Maugeri D; Tribulato A; Lunetta M
    Int J Obes; 1982; 6(1):113-20. PubMed ID: 6121763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged hyperglycaemia during infusion of glucose and somatostatin impairs pancreatic A- and B-cell responses to decrements in plasma glucose in normal man: evidence for induction of altered sensitivity to glucose.
    Dimitriadis G; Cryer P; Gerich J
    Diabetologia; 1985 Feb; 28(2):63-9. PubMed ID: 2858423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
    Orskov L; Alberti KG; Mengel A; Møller N; Pedersen O; Rasmussen O; Seefeldt T; Schmitz O
    Diabetologia; 1991 Jul; 34(7):521-6. PubMed ID: 1916058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a somatostatin analog on insulin requirement and hormone levels in 6 insulin-dependent juvenile-onset diabetics subjected to artificial pancreas.
    Lenti G; Trovati M; Lorenzati R; Vitelli F; Tagliaferro V; Marocco A; Pagano G
    Acta Diabetol Lat; 1980; 17(1):9-14. PubMed ID: 6106342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a long-acting somatostatin analogue on postprandial hyperglycemia in insulin-dependent diabetes mellitus.
    Dimitriadis G; Tessari P; Gerich J
    Metabolism; 1983 Oct; 32(10):987-92. PubMed ID: 6136893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS; Ho LT
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans.
    Carpentier A; Patterson BW; Leung N; Lewis GF
    Diabetes; 2002 Jun; 51(6):1867-75. PubMed ID: 12031975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin effect in postprandial hypoglycemia.
    Baschieri L; Antonelli A; del Guerra P; Fialdini A; Gasperini L
    Metabolism; 1989 Jun; 38(6):568-71. PubMed ID: 2566889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of pulsatile insulin infusion in the elderly.
    Paolisso G; Salvatore T; Sgambato S; Torella R; Varricchio M; D'Onofrio F
    Acta Endocrinol (Copenh); 1990 Jul; 123(1):19-23. PubMed ID: 1975147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.